Reference health
The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model
28/28 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 28 checked references that resolve
resolves10.3109/13693786.2012.692489
Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against<i>Candida</i>species are reduced by farnesol
resolves10.1586/14787210.2015.1056162
Combinatorial drug approaches to tackle<i>Candida albicans</i>biofilms
resolves10.1016/j.riam.2013.09.006
Efficacy of ravuconazole in a murine model of vaginitis by Candida albicans
resolves10.1128/IAI.68.2.651-657.2000
Effects of Reproductive Hormones on Experimental Vaginal Candidiasis
resolves10.1080/13693780601164298
Therapeutic efficacy of posaconazole against isolates of<i>Candida albicans</i>with different susceptibilities to fluconazole in a vaginal model
resolves10.1111/j.1567-1364.2012.00837.x
The metabolic response of<i>Candida albicans</i>to farnesol under hyphae-inducing conditions
resolves10.1080/02681219680000231
Comparisons of the susceptibilities of planktonic and adherent<i>Candida albicans</i>to antifungal agents: a modified XTT tetrazolium assay using synchronised<i>C. albicans</i>cells
resolves10.1111/j.1348-0421.2008.00044.x
Protective effects of farnesol against oral candidiasis in mice
resolves10.1128/AEM.67.7.2982-2992.2001
Quorum Sensing in the Dimorphic Fungus
<i>Candida albicans</i>
Is Mediated by Farnesol
resolves10.1128/AAC.48.6.2305-2307.2004
Enhanced Production of Farnesol by
<i>Candida albicans</i>
Treated with Four Azoles
resolves10.1111/j.1567-1364.2006.00121.x
Effect of farnesol on<i>Candida dubliniensis</i>biofilm formation and fluconazole resistance
resolves10.1093/jac/dku374
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms
resolves10.1016/j.ijantimicag.2016.01.007
Effect of caspofungin and micafungin in combination with farnesol against Candida parapsilosis biofilms
resolves10.1556/AMicr.61.2014.1.6
Serum interleukin-6 levels in murine models of Candida albicans infection
resolves10.2217/fmb.09.98
Cellular interactions of farnesol, a quorum-sensing molecule produced by
<i>Candida albicans</i>
resolves10.1128/AAC.43.12.2841
Interaction between Fluconazole and Amphotericin B in Mice with Systemic Infection Due to Fluconazole-Susceptible or -Resistant Strains of
<i>Candida albicans</i>
resolves10.1002/jobm.201100158
Effect of exogenous administration of <i>Candida albicans</i> autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis
resolves10.1080/13693780410001731547
Assessing<i>in vitro</i>combinations of antifungal drugs against yeasts and filamentous fungi: comparison of different drug interaction models
resolves10.1128/IAI.01182-06
Effect of Farnesol on a Mouse Model of Systemic Candidiasis, Determined by Use of a
<i>DPP3</i>
Knockout Mutant of
<i>Candida albicans</i>
resolves10.1016/j.drup.2010.09.002
Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: Time for harmonization of CLSI and EUCAST broth microdilution methods
resolves10.1038/nprot.2008.141
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
resolves10.1128/AEM.68.11.5459-5463.2002
Inhibition of
<i>Candida albicans</i>
Biofilm Formation by Farnesol, a Quorum-Sensing Molecule
resolves10.1128/AAC.00344-11
The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans
resolves10.1371/journal.ppat.1000828
Dispersion as an Important Step in the Candida albicans Biofilm Developmental Cycle
resolves10.1128/AAC.06082-11
<i>In Vitro</i>
Interactions between Aspirin and Amphotericin B against Planktonic Cells and Biofilm Cells of Candida albicans and C. parapsilosis
The 2 references without a DOI — listed, not checked
no DOI — not checkedClinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, 3rd ed. M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
no DOI — not checkedO’Toole, G.A. 2011. Microtiter dish biofilm formation assay. J. Vis. Exp. 47, pii: 2437.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1007/s12275-016-6298-y"><img src="https://citestamp.com/citestamped/10.1007/s12275-016-6298-y/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1007/s12275-016-6298-y)